Ganirelix Acetate

Ganirelix Acetate Struktur
123246-29-7
CAS-Nr.
123246-29-7
Englisch Name:
Ganirelix Acetate
Synonyma:
GANIRELIX;Ganirelixum;5-?dihydroxy-;3-?bis[[3-?(3;ganirelix Acetate;Ganirelix DiAcetate;Ganirelix Impurity 1;Ganirelix Acetate API;Ganirelix Acetate USP/EP/BP;4-?dihydroxyphenyl)?-?1-?oxo-?2-?propen-?1-?yl]?oxy]?-?4
CBNumber:
CB61370494
Summenformel:
C80H113ClN18O13
Molgewicht:
1570.34
MOL-Datei:
123246-29-7.mol

Ganirelix Acetate Eigenschaften

Sequenz
Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-Tyr-D-Har(Et2)-Leu-Har(Et2)-Pro-DAla-NH2

Sicherheit

HS Code  3504009000

Ganirelix Acetate Chemische Eigenschaften,Einsatz,Produktion Methoden

Originator

Antagon,Organon

Therapeutic Function

LHRH antagonist

Clinical Use

Ganirelix acetate is an analog of GnRH with substitutions at residues 1, 2, 3, 6, 8, and 10. It is not a superagonist but, rather, is a synthetic decapeptide with high antagonist activity and the first GnRH antagonist to be marketed. It is approved for the suppression of LH surges in women who are undergoing ovarian hyperstimulation fertility treatment; LH surges normally promote ovulation. The goal of this drug is to significantly reduce the number of medication days necessary to suppress the LH surge, thereby maintaining eggs in the ovaries. In vitro fertilization (IVF) treatment cycles were historically initiated by the administration of leuprolide acetate to suppress the premature release of LH. This inhibits ovulation so that the eggs remain available for retrieval by a fertility specialist. For this purpose, leuprolide acetate usually is injected for as many as 26 days. Clinical studies have shown that ganirelix acetate can shut down the LH surge in only 5 days of treatment, that the suppression of LH is more pronounced than that of FSH, and that the shorter treatment time minimizes unpleasant side effects, such as hot flashes and headaches.

Ganirelix Acetate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Ganirelix Acetate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 146)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152
Mandy@hangyubiotech.com China 10978 58
Shanghai Affida new material science and technology center
+undefined15081010295
admin@oudaxin.com China 114 58
hebei hongtan Biotechnology Co., Ltd
+86-86-1913198-3935 +8617331935328
sales03@chemcn.cn China 973 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+8618740459177
sarah@tnjone.com China 1142 58
Alpha Biopharmaceuticals Co., Ltd
+86-15542445688
sales@alabiochem.com China 888 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21675 55
Shenzhen Nexconn Pharmatechs Ltd
+86-755-89396905 +86-15013857715
admin@nexconn.com China 10259 58
Shaanxi Pioneer Biotech Co., Ltd .
+8613259417953
sales@pioneerbiotech.com China 3000 58
Shanghai Longyu Biotechnology Co., Ltd.
+8613917842738
info@longyupharma.com China 2534 58
career henan chemical co
+86-0371-86658258 +8613203830695
factory@coreychem.com China 29826 58

123246-29-7()Verwandte Suche:


  • Ac-DNal-DCpa-DPal-Ser-Tyr-DHar(Et2)-Leu-Har(Et2)-Pro-DAla -NH2
  • ganirelix Acetate
  • GANIRELIX
  • Ganirelixum
  • Ganirelix Acetate USP/EP/BP
  • Ganirelix Impurity 1
  • Ganirelix Acetate API
  • 3-?bis[[3-?(3
  • 4-?dihydroxyphenyl)?-?1-?oxo-?2-?propen-?1-?yl]?oxy]?-?4
  • 5-?dihydroxy-
  • Ganirelix DiAcetate
  • 123246-29-7
  • 23246-29-7
  • C80H113ClN18O13
  • hormones
Copyright 2019 © ChemicalBook. All rights reserved